Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2020 | Liquid biopsy: a new era

Samreen Ahmed • 31 Jan 2020
BTOG 2020
Lung Cancer

Samreen Ahmed, FRCP, MD, University Hospitals of Leicester, UK, talks on liquid biopsy technology, measurable residual disease (MRD) and the use of these techniques to aid earlier intervention. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

More from Samreen Ahmed

3:29
Novel strategies to treating brain metastases in lung cancer
Samreen Ahmed • 27 Mar 2023
0:54
Early lung cancer at ELCC 2023
Samreen Ahmed • 27 Mar 2023
0:55
Management of brain metastases associated with lung cancer
Samreen Ahmed • 27 Mar 2023
3:06
Highlights from the BTOG 2023 therapeutics symposium
Samreen Ahmed • 26 Apr 2023

Related Videos

2:45
Assessing operability in NSCLC: challenges and considerations
Mariana Brandao • 18 Apr 2024
2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
1:47
Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial
Robert Rintoul • 19 Apr 2024
7:37
What is the optimal follow-up for lung cancer long term survivors?
Robert Rintoul • 19 Apr 2024
The content of VJOncology is intended for healthcare professionals